AI Visibility Scorecard
Precision Antibodies for Next Generation Obesity Therapies
ibioinc.com · Healthcare
Somewhat visible. AI bots can read Precision Antibodies for Next Generation Obesity Therapies, but it is missing the structured signals that push citation rate above competitors.
AI engines read this profile 5 times
Claude · ShapBot
#7,042 of 924,420 in Healthcare for AI visibility
38
5
AEO Visibility
iBorderline · 5.2/10
0
Muse Index Score
iAI agent readiness
Not agent-ready · 0/100
8
AI Adoption
iBasic · 8/100
Business relationships
1 company linked through SEC annual reports. See customers, suppliers and partners →
About Precision Antibodies for Next Generation Obesity Therapies
from our crawl and measurement
Precision Antibodies for Next Generation Obesity Therapies, based in San Diego, CA, describes itself simply: "iBio develops novel therapies for obesity and cardiometabolic disorders using its patented AI drug discovery platform." Its AI visibility score is 5.2 out of 10: the engines can find it, but they do not have much to hold on to.
Our crawl found a readable heading structure. It is missing structured data describing the business, an llms.txt file and a sitemap.
AI crawlers have visited 5 times in our tracking, including ClaudeBot (Anthropic) and ShapBot (Parallel).
The 6 signals AI reads
Strong · Good · Fair · Weak
Structured Data
Weak
Organization / LocalBusiness JSON-LD that AI can read.
Content Structure
Fair
Clear headings and answer-style content.
Entity Clarity
Fair
How clearly your brand identity reads to AI.
E-E-A-T Signals
Experience, Expertise, Authority, Trust
Fair
Experience, Expertise, Authority, Trust markers.
Technical AEO
Fair
robots.txt, llms.txt, and AI-bot crawl access.
AI Discoverability
Fair
Sitemaps and entity links AI can follow.
Off-page authority
How the web signals your brand to AI
Backlinks
Strong
Inbound links from other sites.
Domain Authority
Fair
Established authority for your domain.
Reference Presence
Weak
Not in AI knowledge graphs yet.
News & Press
Weak
No press coverage found yet.
Community
Weak
No community discussion yet.
Social Mentions
Weak
No social discussion found yet.
What this score means
Your AEO score measures whether AI search engines - ChatGPT, Claude, Perplexity, Gemini - can actually read your site and cite it in answers. Roughly two-thirds of sites are invisible to them. At 5.2/10, Precision Antibodies for Next Generation Obesity Therapies has a working base to build on - fixable, and the signals above are where to start.
Is this your brand?
The exact fixes for Precision Antibodies for Next Generation Obesity Therapies
Which AI engines already crawl you
Free AI bot monitoring: see every AI crawler that visits you
Already have an account? Sign in
How to Get Your Brand Cited by ChatGPT, Gemini, and Claude: The Complete AEO Guide
The search landscape has fundamentally shifted. While Google still dominates, millions of users now ask questions to ChatGPT, Gemini, and Claude instead of typing into a search bar.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for Precision Antibodies for Next Generation Obesity Therapies.
Source & Attribution
Scored by Engagemii on October 25, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/ibioinc
Cite this score: Engagemii (2026). "AEO Score for Precision Antibodies for Next Generation Obesity Therapies." Retrieved from https://engagemii.com/aeo/brands/ibioinc
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - The Answer Engine Optimization (AEO) Platform